The future of the internet is 3D, and people will increasingly create and express themselves in 3D. Sloyd is using automation to make the creation of 3D faster and more accessible and to make 3D rendering more efficient. We are building a simple-to-use WebApp to quickly generate 3D assets and a software development kit for performance-efficient runtime creation in video games and virtual worlds. Sloyd combines procedural generation techniques, machine learning, and a commitment to real-time optimization to provide the best 3D automation tools. Sloyd is a remote-first company and employees can work from home, a shared-space hub, or from the main office in Oslo. We don’t care where you come from, we only care about your passion and creativity.

Iterate is an ecosystem for digital innovation, and we like to describe ourselves as a company that builds companies. We contribute from A-Z when building, starting with creating concepts based on key insights to launching and improving products whilst living in the marketplace. We find the right team and work toward the company culture that enables us to deliver value to our customers quickly. The key to achieving this is reinvesting all our profits in the ideas of our employees, or selected entrepreneurs. Five years into this strategy, we own shares in fifteen ventures; all of which are showing promising results. Our 70 designers, developers, and product managers just moved into new locations in the center of Oslo. 
Close collaboration with our customers is key to our success. They provide domain know-how, and we provide tools, strategies, and experts. Together we uncover the best way that connects your strategy and idea with the market needs. Our goal is to achieve minimum risk and give our customers the best possible starting point for scaling, on their own, or in continued collaboration.

UpStacked is the All-in-One centralized operations platform that crushes SLA requirements to increase profitability and reduce OPEX. Purpose-built for internal IT and MSPs to operate SMBs and Enterprises. With user experience in mind, UpStacked drives complex to zero-touch, through automation and machine learning. UpStacked at a Glance: - All-in-One Centralized Platform - Enterprise onboarding in minutes - Third-Party integrations - Zero-Touch - Simplified License Management - Real-Time On-Demand Reporting - Real-Time Topology Based Correlation - Real-Time Event-Based Correlation - Built-in Role Based Access Control - Natively Multi-Tenant - Multi-Vendor - ITIL

An intracellular approach to diagnostics – changing the way diagnostics approach blood tests. Pre Diagnostics is the first diagnostics company to focus on intracellular measurements of disease-specific biomarkers inside the blood cells. We extract disease-relevant information from biomarkers located inside specific blood cells called monocytes to provide actionable results for patients and practitioners.

New drugs for treating diseases of Down syndrome. More than 1% of the global GDP is spent on nursing demented people, and the number requiring nursing will triple within 2050. The disease is progressive, leading to death. There is no current cure available, only symptomatic treatments. Individuals born with Down syndrome have a more than 10x risk of developing dementia as well as a host of other diseases including diabetes. Our drug target, DYRK1A is an enzyme found on chromosome 21, and is considered a key factor determining developmental and medical challenges faced by individuals with Down. The enzyme interacts with multiple biological mechanisms involved in Alzheimer’s and autoimmune diseases. Advanced drug designUsing advanced drug design technologies, we have designed a potent DYRK1A inhibitor drug, PST-900. A use and substance of matter patent have been applied for. The company is currently working on chemical Lead Optimisation with 8 full-time medicinal chemists contracted.Financing and milestonesThe Company raised NOK 5 million in 2015 and 8.8 MNOK in 2016/2017, matching non-dilutive research (BIA) and business grants (Innovation Norway). We demonstrated Proof of Principle in a model system for Alzheimer’s disease in 2Q2016. We have also demonstrated that our drug is capable of reversing diabetes in an animal model. Together with clinical and regulatory advisors, we have identified an important unmet need for a drug to treat newly diagnosed diabetes. We will use this indication to quickly progress to market and from there develop analogous drug molecules in Alzheimer’s disease, focused especially in Down syndrome. Funding soughtThe current funding round will raise 15+ MNOK to fund the progression to the final Development Candidate during 2018. Following this, further funding will be sought to perform toxicology/safety and Phase 1 clinical studies. A highly experienced teamThe team behind Pharmasum Therapeutics have broad, international pharmaceutical and biotechnology experience, and is supported by an excellent group of advisors. Anders Fugelli, Ph.D., CEO. John Sigurd Svendsen, Ph.D., CSO. Pauline Stewart-Long, Ph.D. Project Management. Henning Mork, CFO. Board of Directors: Andrew Parsons, PhD. Øystein Soug, MSc. Mark Treherne, PhD, John Sigurd Svendsen, PhD.

Vi tør å tenke nytt i en bransje som er preget av umoderne arbeidsformer, og kombinerer tung juridisk kompetanse med markedsledende teknologi. LIGL ble startet for å utfordre den konservative advokatbransjen, og bygger på tre grunnleggende prinsipper, kompetanse, kultur og teknologi – vårt DNA. Gjennom innovativ bruk av teknologi, en moderne forretningsmodell og et unikt arbeidsmiljø, vil vi skape et reelt, effektivt og eksklusivt alternativ til de største advokatfirmaene i Norge. Vi vet at dette vil og må ta tid, men vi vet også at det er denne veien bransjen vil utvikle seg – og vi ønsker å være i forkant. LIGL består av topp kvalifiserte forretningsadvokater med lang fartstid, solid faglig ekspertise og entusiasme for den jobben de gjør. Flere av firmaets advokater kommer fra ledende partnerstillinger i landets største advokatfirmaer. Kundene våre er norske og internasjonale virksomheter. Vi bistår alt fra gründervirksomheter i oppstart, til store selskaper med en lang historie å se tilbake på. Vi tar også oppdrag for privatpersoner innenfor utvalgte rettsområder. Firmaet leverer advokattjenester innen følgende fagområder: - Corporate, strategisk selskapsrettslig rådgivning - Rekonstruksjon & insolvens - Immaterialrett & teknologi - Fast eiendom - Skatt - Tvisteløsning Firmaets advokater er dyktige tverrfaglige forretningsadvokater, og firmaet tar derfor også oppdrag innenfor andre fagområder som naturlig leveres av et kompetent forretningsadvokatfirma, som arbeidsrett, kontraktsrett, entreprise etc.

Vimond provides online streaming software and services for broadcasters and content providers worldwide. Our local team counts 62 people from 17 nations, of which a majority are developers with a strong passion and expertise in online video workflows and innovative software and web development. As we continue to grow our team, we are always looking for people with relevant experience in media technology, software development, product development, system administration & dev ops, tech team lead roles, project management, account management, and solution architect roles. Contact us for an informal chat!

We are a young production company in growth – our mission is to bring the customer closer to the production and help them shape their idea. Now we are looking to fill our team with two positions– CNC operator to our brand new 5-axis Biesse with edge banding. You need to have experience with similar machines.– Cabinet makers with experience in both of these positions will be a big part of our team and central in shaping the path for the company into the future. Interested? send us a mail: at kristoffer@cutfab.no and we will provide you with more information.Materials we work with:- Plywood- Acrylic- Solidwood- MDF- Aluminum- D-board- Foam- PVCInterested? send us a mail: at kristoffer@cutfab.no and we will provide you with more information.

DoMore Diagnostics is on a mission to transform cancer diagnostics with artificial intelligence to improve patient care and make drug development more effective. We use state-of-the-art methods to improve patients’ quality of life and help clinicians make more informed decisions. Our technology is based on pioneering research on utilizing artificial intelligence to increase the prognostic value from routine clinical pathology cancer tissue samples. The extensive research conducted at top universities (University in Oslo, Oxford University and University College of London) has been published in leading and high impact scientific journals such as The Lancet and Nature Reviews Cancer. These new methods have resulted in fully automated histotyping that provide objective and precise prognostic information that correlate and out-perform existing markers. This novel histotyping can guide selection of therapy to avoid over- and undertreatment. It can also make cancer drug development more effective by ensuring more precise diagnosis and prognosis, which is the fundament for precision medicine. Artificial intelligence is set for a breakthrough in medicine and several megatrends are pushing for new solutions in cancer diagnostics. Digital pathology and new AI algorithms will play a significant role in the future of medicine and hold multiple commercial opportunities. DoMore Diagnostics is at the forefront of the field and will bring these next generation products to the clinic.

Hybel is bringing reputability and automation to the private residential tenancy management market by providing a marketplace to match prospective tenants with landlords, as well as automating the day-to-day tasks of property management. We think there are too many bad-actors within the private residential rental market and are providing a platform where tenants & landlords can have successful tenancies and facilitate understanding their rights, responsibilities and obligations.

Ferdia har som mål å digitalisere og fornye turbussbransjen gjennom en Uber-lignende tilnærming. Vi skal revolusjonere turbussmarkedet gjennom å digitalisere små og mellomstore turbusselskap og ved å gjøre det mye enklere å leie og bruke turbusser. Det være seg til firmaturer, festivaler eller fotballkamper. Turbussbransjen i Europa er preget av et stort antall busselskap og lite digitalisering. 85% av tiden står bussene parkert eller kjører på veien uten passasjerer i setene. Våre nye digitale tjenester kombinert med maskinlæring og rute-optimalisering vil gjøre det mulig å utnytte bussenes kapasitet mye mer effektivt enn i dag. Vi har fått støtte fra Innovasjon Norge, inngått samarbeid med Tide, et av Norges største busselskap, og har begynt arbeidet med internasjonalisering. Dette blir et spennende år!

Campanyon is a booking platform for nature and sustainable accommodation, where you can find and book campsites, glamping, private properties like farms, RV spots and more. Campanyon was founded in 2020 and is on a mission to make nature accessible for everyone, by building the world’s biggest community of responsible travelers and hosts.

Fishby is a recreational sport fishings industry's very own "Google". Through our platform, a fisherman can buy ANY fishing permit in Norway (for now), even those that don't exist yet. The best thing is that we can do it WITHOUT needing the landowner/permit seller to pre-register on the platform or even know about us. It is a trading channel between the fisherman and landowner, and It is as simple as sending a "friend`s request" on Facebook. However, here you are not making friends, you are asking people if you are allowed to fish on their land and for what price.

Orixe solves the problem of counterfeit parts (pirate products) and supply chain uncertainty across multiple industries. This problem with counterfeit parts and false certificates is especially prevalent in the aerospace, automotive and electronics industry, but can be said to be a cross-industry problem. Counterfeit parts create problems for producers such as faulty products (as seen in the cases Fake medical masks, Samsung Galaxy Note 7, or the Takata airbags), but also that goods do not adhere to regulations such as REACH and RoHS or comply with quality requirements. Companies risk severe financial damage such as: - loss in sales, - not meeting quality standards, - lawsuits and - lost reputation. The Orixe Platform has been developed in close cooperation with out pilot customer within the defense- and aerospace industry to solve the cross-industry problem of counterfeit parts. Orixe ensures integrity and transparency by tracing components country of origin and their adherance to regulations, i.e REACH and RoHS. The solution is a new way of combining database and blockchain that effectively and securely tracks transactions between companies. This creates a secure image of the supply chain which raises effectivity in quality- and supplier assurance. To make it easier for our customers to be sure of their suppliers quality standards and reduce time and effort spent on quality assurance, Orixe is also providing a solution that automates the process of auditing suppliers. Orixe is a company that is devoted to creating a more sustainable future. Many of the global challenges that we face today such as pollution, corruption and modern slavery are hidden i dark supply chains. By providing a solution that makes supply chains transparent we reduce the risk of unethical behavior within the supply chain, and help companies to fulfill the UN Sustainable Development Goals.

We are a startup passionate about facilitating great, beneficial relationships between companies and their leads. With support from notable investors and sizable clients, we aim at providing the foremost platform for attracting and engaging leads. We believe in authentic journeys - and inviting your customers to be a part of yours.